Dr. Asolina Braun studied biology and pursued a doctoral degree at Hannover Medical School in Germany with Reinhold Förster and Tim Worbs. Here, she employed a novel micro-surgical procedure of intralymphatic injection together with multi-photon microscopy to study chemokine-driven migration of lymph-derived immune cells. A fellowship from the German Research Foundation enabled her to undertake post-doctoral studies with Francis Carbone and Thomas Gebhardt which focused on how cytokines enable the retention and differentiation of tissue-resident memory T cells (TRM) in extra-lymphoid tissues, particularly skin. During this time, she has contributed to the field by defining survival factors and differentiation signals for TRM and developed a strong interest in skin immunology. In 2018, she joined Tony Purcell at Monash University to study antigen presentation in psoriasis. She continues to work on skin immune responses in the context of psoriasis as a group leader at Monash University. This work strives to develop novel therapeutic avenues of tolerance induction in autoinflammatory skin diseases.
Dr. Asolina Braun studied biology and pursued a doctoral degree at Hannover Medical School in Germany with Reinhold Förster and Tim Worbs. Here, she employed a novel micro-surgical procedure of intralymphatic injection together with multi-photon microscopy to study chemokine-driven migration of lymph-derived immune cells. A fellowship from the German Research Foundation enabled her to undertake post-doctoral studies with Francis Carbone and Thomas Gebhardt which focused on how cytokines enable the retention and differentiation of tissue-resident memory T cells (TRM) in extra-lymphoid tissues, particularly skin. During this time, she has contributed to the field by defining survival factors and differentiation signals for TRM and developed a strong interest in skin immunology. In 2018, she joined Tony Purcell at Monash University to study antigen presentation in psoriasis. She continues to work on skin immune responses in the context of psoriasis as a group leader at Monash University. This work strives to develop novel therapeutic avenues of tolerance induction in autoinflammatory skin diseases.